OpenAlex
PricingAboutJobs
Log inGet started
Work

CD44v6: a target for antibody-based cancer therapy

HTML

Year: 2004
Type: article
Source: Cancer Immunology Immunotherapy
DOI: 10.1007/s00262-003-0494-4
Authors: Karl-Heinz Heider, Hartmut Kuthan, Gerd Stehle, Gerd Munzert
Institutions: Boehringer Ingelheim (Austria), Boehringer Ingelheim (Germany)
Language: English

Topic: Proteoglycans and glycosaminoglycans research
Subfield: Cell Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: CD44v6, CD44 variant isoforms, alternative splicing, antibody-based cancer therapy, tumor invasion, metastasis, squamous cell carcinoma, adenocarcinoma, epithelial tumors, tumor-associated antigens, normal tissue expression
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2064505748
FWCI: 1.791
Cites: 132
Cited by: 185
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms